BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Nov. 9, 2005
View Archived Issues
ExonHit Launches 6.5M IPO On Alternext Market
PARIS - ExonHit Therapeutics SA launched an initial public offering on the Alternext market of the Euronext stock exchange in Paris Nov. 8, hoping to raise 6.5 million (US$7.6 million). (BioWorld International)
Read More
Raising Drug Prices In Europe Suggested As Solution For U.S.
Read More
Molecular Mimic Could Lead To New Immunotherapeutics
Read More
DOR Buying Gastrotech For $39M In Shares, Milestones
Read More
Fovea Brings In $25M For Retinal Disease Research
Read More
Ariana Signs With Pasteur Institute, Picks Up Funding
Read More
Vernalis Paying Mylan $23M For U.S. Rights To Apokyn
Read More
Other News To Note
Read More